Social Media Ideas for Gnpx

What Is NGP Enixytilâ„¢? N.G.P Tobacco ApS Explains Its Modified Caffeine Technology

N.G.P Tobacco ApS provides an overview of NGP Enixytilâ„¢, its proprietary modified caffeine technology developed specifically for modern oral delivery systems and Performance Pouc...

AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”

AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...

GPIX: I Would Use This 8% Yielder As A Core Holding

Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin

Geron

Geron Anonymous (not verified) Sat, 08/01/2026 - 21:26 field_thread_url https://cafepharma.com/boards/threads/geron.694511/ board name...

Precigen, Inc. (PGEN) Q2 2026 Earnings Call Transcript

Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Pro...

Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder

FDA raises no objection to the Company's planned Phase 1 program design, dose-escalation approach, or CMC and nonclinical packages; IND submission remains on track for the fourth q...

argenx SE (ARGX) Forte Biosciences, Inc. - M&A Call - Slideshow

Syndax

Syndax Anonymous (not verified) Sun, 07/19/2026 - 15:19 field_thread_url https://cafepharma.com/boards/threads/syndax.695213/ board name...

BioXcel

BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...

Agenus surges on study pivot; Apnimed lines up an IPO

Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA...